2013
Dose Escalation, Not “New Biology,” Can Account for the Efficacy of Stereotactic Body Radiation Therapy With Non-Small Cell Lung Cancer
Brown JM, Brenner DJ, Carlson DJ. Dose Escalation, Not “New Biology,” Can Account for the Efficacy of Stereotactic Body Radiation Therapy With Non-Small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2013, 85: 1159-1160. PMID: 23517805, PMCID: PMC3608927, DOI: 10.1016/j.ijrobp.2012.11.003.Peer-Reviewed Original Research
2008
SU‐GG‐T‐509: Impact of Gating On Dose Escalation in Lung Cancer Patients
Antony J, Loo B, Carlson D, Maxim P, Luxton G, Xing L. SU‐GG‐T‐509: Impact of Gating On Dose Escalation in Lung Cancer Patients. Medical Physics 2008, 35: 2842-2842. DOI: 10.1118/1.2962258.Peer-Reviewed Original ResearchNormal tissue complication probabilityDose escalationTumor marginsInferior tumor marginMean lung doseLocal tumor controlLung cancer patientsTreatment planningConformal radiation therapyTumor motionTumor control probability modelCRT plansLeft lungMediastinal tumorLung doseTumor controlCancer patientsToxicity CriteriaLung tumorsRadiation therapyDose changesLyman-KutcherBurman modelDose constraintsPatients